Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2009 - 2026)

Bausch Health Companies (BHC) reported Liabilities and Shareholders Equity of $24.5 billion for Q1 2026, down 7.28% on a YoY basis from $26.4 billion in Q1 2025, and down 7.08% sequentially from $26.4 billion in Q4 2025.

Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $24.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 7.28% year-over-year to $24.5 billion; the trailing twelve-month figure through Mar 2026 stood at $105.0 billion (down 0.97% YoY), and the FY2025 full-year result was $26.4 billion, down 0.59% from the prior year.
  • Liabilities and Shareholders Equity slipped to $24.5 billion in Q1 2026, from $26.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $29.1 billion in Q1 2022 to a low of $24.5 billion in Q1 2026.
  • A 5-year average of $26.6 billion and a median of $26.5 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Peak annual rise in Liabilities and Shareholders Equity reached 6.48% in 2023, while the deepest fall reached 12.53% in 2023.
  • Tracing BHC's Liabilities and Shareholders Equity over 5 years: stood at $25.7 billion in 2022, then advanced by 6.48% to $27.4 billion in 2023, then decreased by 3.02% to $26.5 billion in 2024, then fell by 0.59% to $26.4 billion in 2025, then dropped by 7.08% to $24.5 billion in 2026.
  • Business Quant data shows BHC's Liabilities and Shareholders Equity at $24.5 billion in Q1 2026, $26.4 billion in Q4 2025, and $26.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 24.50 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.50 Bn
Dec 31, 2025 26.37 Bn
Sep 30, 2025 26.82 Bn
Jun 30, 2025 27.27 Bn
Mar 31, 2025 26.42 Bn
Dec 31, 2024 26.52 Bn
Sep 30, 2024 26.54 Bn
Jun 30, 2024 26.50 Bn
Mar 31, 2024 26.91 Bn
Dec 31, 2023 27.35 Bn
Sep 30, 2023 27.06 Bn
Jun 30, 2023 25.50 Bn
Mar 31, 2023 25.45 Bn
Dec 31, 2022 25.69 Bn
Sep 30, 2022 26.30 Bn
Jun 30, 2022 28.17 Bn
Mar 31, 2022 29.09 Bn
Dec 31, 2021 29.20 Bn
Sep 30, 2021 29.25 Bn
Jun 30, 2021 30.04 Bn